Loading…
Living Donor Protection Act of 2016
Legislative Progress
Introduced
February 25, 2016
Latest Action
February 26, 2016
Primary Sponsor
Jerrold NadlerDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
27pct
1d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Living Donor Protection Act of 2016 This bill prohibits discrimination based on an individual's status as a living organ donor in the offering, issuance, cancellation, coverage, price, or any other condition of a life insurance policy, disability insurance policy, or long-term care insurance policy. The bill amends the Family and Medical Leave Act of 1993 to specifically include living organ donation as a serious health condition that entitles a covered employee to leave under that Act. The Department of Health and Human Services must update public service announcements, websites, and other media regarding live organ donation to educate the public on the benefits of live organ donation and access to insurance for living organ donors.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2016 · fourth_quarter · Health Issues
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Government Reform, House Administration, Education and the Workforce, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Client expense: $65,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · fourth_quarter · Labor Issues/Antitrust/Workplace
The Standard Merger and Acquisition Act of 2016 (H.R.4616/S.2584) - support.
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2016 · fourth_quarter · Health Issues
Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support; support for Zika supplemental funding; The Living Donor Protection Act of 2016 (H.R.4616/S.2584) - support; The Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 2745) - support; proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose; Congressional letter supporting reforms to the liver transplant allocation system - support; discussions with HHS regarding how to handle cybersecurity issues; hospital issues related to repeal and replace of the Affordable Care Act; Senate Finance Committee guidance on concurrent surgeries.
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2016 · fourth_quarter · Medicare/Medicaid
End stage renal disease (ESRD) rebasing, Medicare reimbursement and payment reform. CMS's Center for Medicare and Medicaid Innovation's comprehensive ESRD Care Initiative and improving overall ESRD patient health quality. Improved policies on chronic kidney disease. Chronic care management reform legislation. ESRD Integrated Care legislation. Transplant Initiatives. Implementation of the Medicare Access and CHIP Reauthorization Act. Living Donor Protection Act (H.R. 4616/S. 2584) ESRD Choice Act (H.R. 5659) Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942) Creating High-Quality Results & Outcomes Necessary to Improve Chronic (CHRONIC) Care Act (S. 3504) 21st Century Cures Act, provisions related to ESRD coverage in Medicare Advantage Medicare Third Party Payment
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), SENATE
2016 · fourth_quarter · Medicare/Medicaid
End stage renal disease (ESRD) rebasing, Medicare reimbursement and payment reform. CMS's Center for Medicare and Medicaid Innovation's comprehensive ESRD Care Initiative and improving overall patient health quality. Improved policies on chronic kidney disease. Chronic Care management reform legislation. ESRD Integrated Care Legislation. Transplant Initiatives. Living Donor Protection Act (H.R. 4616/S. 2584) ESRD Choice Act (H.R. 5659) Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942) Implementation of the Medicare Access and CHIP Reauthorization Act Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act(S. 3504) 21st Century Cures Act, provisions related to ESRD coverage in Medicare Advantage
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Client expense: $65,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Implementation of the National Research Pediatric Research Act, all provisions; Administrations Cancer Moonshot initiative, ensure appropriate representation of pediatric issues; H.R. 4616 Living Donor Act Protection Act, all provisions; S.2584 Living Donor Act Protection Act, all provisions
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Labor Issues/Antitrust/Workplace
The Standard Merger and Acquisition Act of 2016 (H.R.4616/S.2584) - support.
Client expense: $410,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2016 · third_quarter · Health Issues
Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support; support for Zika supplemental funding; The Living Donor Protection Act of 2016 (H.R.4616/S.2584) - support; The Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 2745) - support; proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose; Congressional letter supporting reforms to the liver transplant allocation system - support; discussions with HHS regarding how to handle cybersecurity issues.
Client expense: $410,000 · Firm income: Not reported
2016 · third_quarter · Medicare/Medicaid
End stage renal disease (ESRD) rebasing, Medicare reimbursement and payment reform. CMS's Center for Medicare and Medicaid Innovation's comprehensive ESRD Care Initiative and improving overall patient health quality. Improved policies on chronic kidney disease. Chronic Care management reform legislation. ESRD Integrated Care Legislation. Transplant Initiatives. Living Donor Protection Act (H.R. 4616/S. 2584) ESRD Choice Act (H.R. 5659) Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942)
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
End stage renal disease (ESRD) rebasing, Medicare reimbursement and payment reform. CMS's Center for Medicare and Medicaid Innovation's comprehensive ESRD Care Initiative and improving overall ESRD patient health quality. Improved policies on chronic kidney disease. Chronic care management reform legislation. ESRD Integrated Care legislation. Transplant Initiatives. Implementation of the Medicare Access and CHIP Reauthorization Act. Living Donor Protection Act (H.R. 4616/S. 2584) ESRD Choice Act (H.R. 5659) Dialysis PATIENT Demonstration Act (H.R. 5506/S. 3090/H.R. 5942)
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), SENATE
2016 · second_quarter · Health Issues
Advocacy for CONNECT Act (S. 2484/HR. 4442), particularly home as originating site for home dialysis patients Advocated for the introduction of the Living Donor Protection Act HR 4616/S2584 (living organ donor and transplantation policy) Discussed draft legislation concerning care delivery models for Medicare beneficiaries with kidney disease (including HR 5506/S 3090) Discussed transplantation policy in general Implementation of 2015 TAA/TPA legislation related to AKI care Support for HR1130/S598 (comprehensive kidney care legislation)
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · second_quarter · Health Issues
Advocacy for the 21st Century Cures Act Advocated for the introduction of the Living Donor Protection Act HR 4616/S2584 (living organ donor and transplantation policy) Discussed draft legislation concerning care delivery models for Medicare beneficiaries with kidney disease (including HR 5506/S 3090) Discussed transplantation policy in general Implementation of 2015 TAA/TPA legislation related to AKI care
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · second_quarter · Health Issues
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Client expense: $65,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2016 · second_quarter · Health Issues
Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support; support for Zika supplemental funding; The Living Donor Protection Act of 2016 (H.R.4616/S.2584) - support; The Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 2745) - support; proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose.
Client expense: $330,000 · Firm income: Not reported
2016 · second_quarter · Labor Issues/Antitrust/Workplace
The Standard Merger and Acquisition Act of 2016 (H.R.4616/S.2584) - support.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2016 · second_quarter · Health Issues
Living Donor Protection Act of 2016- H.R. 4616/ S. 2584
Client expense: Not reported · Firm income: $20,000
2016 · first_quarter · Health Issues
Advocacy for the 21st Century Cures Act Advocated for introduction of CONNECT Act HR4442/S2484 (telemedicine in Medicare program) Advocated for the introduction of the Living Donor Protection Act HR 4616/S2584 (living organ donor and transplantation policy) Discussed draft legislation concerning care delivery models for Medicare beneficiaries with ESRD Discussed transplantation policy generally
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office
2016 · first_quarter · Health Issues
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2016 · first_quarter · Labor Issues/Antitrust/Workplace
The Standard Merger and Acquisition Act of 2016 (H.R.4616/S.2584) - support.
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2016 · first_quarter · Health Issues
Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support; support for Zika supplemental funding; The Living Donor Protection Act of 2016 (H.R.4616/S.2584) - support; The Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 2745) - support; proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose.
Client expense: $320,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
Living Donor Protection Act of 2016- H.R. 4616/ S. 2584
Client expense: Not reported · Firm income: $20,000
| House |
| Referred to |
| February 25, 2016 |
| Oversight and Accountability Committee | House | Referred to | February 25, 2016 |
| Democratic |
| NE |
| Brad R. Wenstrup | Republican | OH |
| Chellie Pingree | Democratic | ME |
| Daniel Lipinski | Democratic | IL |
| David Young | Republican | IA |
| Earl Blumenauer | Democratic | OR |
| Eleanor Holmes Norton | Democratic | DC |
| Grace Meng | Democratic | NY |
| Gwen Moore | Democratic | WI |
| Jaime Herrera Beutler | Republican | WA |
| James A. Himes | Democratic | CT |
| Jared Polis | Democratic | CO |
| Jim McDermott | Democratic | WA |
| John A. Yarmuth | Democratic | KY |
| Joyce Beatty | Democratic | OH |
| Kathy Castor | Democratic | FL |
| Kevin Yoder | Republican | KS |
| Lamar Smith | Republican | TX |
| Loretta Sanchez | Democratic | CA |
| Mark DeSaulnier | Democratic | CA |
| Martha McSally | Republican | AZ |
| Matt Cartwright | Democratic | PA |
| Michael C. Burgess | Republican | TX |
| Michael G. Fitzpatrick | Republican | PA |
| Michelle Lujan Grisham | Democratic | NM |
| Peter J. Visclosky | Democratic | IN |
| Peter T. King | Republican | NY |
| Raúl M. Grijalva | Democratic | AZ |
| Robert A. Brady | Democratic | PA |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Scott H. Peters | Democratic | CA |
| Seth Moulton | Democratic | MA |
| Stephen F. Lynch | Democratic | MA |
| Steven M. Palazzo | Republican | MS |
| Suzan K. DelBene | Democratic | WA |
| Ted Lieu | Democratic | CA |
| Tim Ryan | Democratic | OH |
| Yvette D. Clarke | Democratic | NY |
| Zoe Lofgren | Democratic | CA |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office